In the early part of the AH session, there was erroneous information from STAT that eight NVAX subjects had required hospitalization. NVAX opened its CC by saying that zero subjects required hospitalization and that STAT had misinterpreted the online paper about the trial. (STAT subsequently corrected its story.)